Deals
The PE firm has picked up a minority stake in Aragen, valuing the company at around $1.4b.
1
India: Quadria Capital invests $100m in IPO-bound Aragen Life Sciences
2
India Digest: Groww eyes $700m IPO; Ather eyes $2.4b for IPO
3
Arali leads funding in app testing platform Quash and other India deals
4
Vietnam-based PE firm ABB closes second fund at $70m
5
Singapore sovereign wealth fund GIC's CIO said to be stepping down
More Stories
SE Asia Deal Review: Startup funding surges in Dec as megadeals resurface
India’s healthcare boom lures big chunk of $14b private equity money
PE-VC investments in Indian healthcare hold steady in 2024
China’s $47b third semiconductor ‘Big Fund’ kickstarts investments
India’s IPO party likely to continue amid a starry lineup in 2025
IPOs & Markets
Groww is targeting a valuation of $6-8b in the IPO.
The funding also saw participation from Java Capital, PeerCheque, DeVC by Matrix Partners, and Tracxn’s Abhishek Goyal.
Private Equity
The fund has closed below its initial target of $100 million.
People
Jaensubhakij, who took up the role of CIO in 2017, is expected to be succeeded by deputy group CIO Bryan Yeo in April.
India
The round also saw participation from Titan Capital Winners Fund, Global Growth Capital, DEVC, and existing investors.
Singapore
Krishnan will be replaced by Lewis Ng effective March 2025.
Greater China
Qiming Venture Partners and Alpha JWC Ventures also participated in the round.
Xiaoxi Lin’s addition aligns with Morrison Foerster’s strategic growth in Asia.
Three megadeals lifted total fundraising value in Dec 2024.
